SCHEMBL30879261

SCHEMBL30879261

CN1CCN(c2ccc(N)cc2CNCCCO[Si](C)(C)C(C)(C)C)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ RAD52 P43351 2/20 0.40
▸ ALDH1A1 P00352 3/20 0.33
▸ DUT P33316 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ ADRA2C P18825 2/20 0.32
▸ NR1H2 P55055 1/20 0.32
▸ BRD9 Q9H8M2 3/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ GAA P10253 3/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ GFER P55789 2/20 0.32
▸ PTK2B Q14289 2/20 0.32
▸ WDR5 P61964 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ HRH4 Q9H3N8 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30878962 0.84 HTT (0.45) KDM4EALDH1A1POLBGAAKMT2A
SCHEMBL30879139 0.83 MAPT (0.41) MAPTKDM4ERAD52ALDH1A1DUT
SCHEMBL30879152 0.83 MAPT (0.41) MAPTKDM4ERAD52ALDH1A1DUT
SCHEMBL30878902 0.82 MAPT (0.41) MAPTKDM4ERAD52ALDH1A1DUT
SCHEMBL30879170 0.82 KDM4E (0.39) MAPTKDM4ERAD52ALDH1A1L3MBTL1
SCHEMBL30879197 0.81 KDM4E (0.41) MAPTKDM4ERAD52ALDH1A1DUT
SCHEMBL30879274 0.80 MAPT (0.44) MAPTKDM4ERAD52ALDH1A1DUT
SCHEMBL30878880 0.79 MAPT (0.43) MAPTKDM4ERAD52ALDH1A1DUT
SCHEMBL2013678 0.76 MAPT (0.52) MAPTKDM4ERAD52ALDH1A1POLB
SCHEMBL30879219 0.71 HTR7 (0.43) MAPTKDM4ERAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 — — EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 — — WO disclosed
Send feedback